VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > second quarter numbers

<< Previous

Bullboard Posts

Next >>

Comment by WalkOverTheStrton Aug 29, 2023 10:00pm

71 Views

Post# 35611116

RE:RE:RE:second quarter numbers

The NHS was not a sale. Cardinal is full of sh--t. Email Jonathan at JRobinson@oakhillfinancial.ca and he will tell you this
"This is a free upgrade offer to an important customer. The hospital is an important reference site for other potential buyers."
Stop posting Cardinal's bs, he has zero credibility....

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity